SCHEMBL9219191

SCHEMBL9219191

COC1CCCCC1(O)c1cccnc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.47
CHRM1 P11229 2/20 0.47
CHRM4 P08173 1/20 0.47
CHRM5 P08912 1/20 0.47
CHRM3 P20309 1/20 0.47
CNR2 P34972 1/20 0.44
OPRM1 P35372 4/20 0.43
OPRL1 P41146 2/20 0.43
SLC6A9 P48067 1/20 0.43
ALDH1A1 P00352 2/20 0.38
MAPT P10636 1/20 0.38
GAA P10253 1/20 0.38
SLC22A1 O15245 3/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9219188 1.00 CHRM2 (0.47) CHRM2CHRM1CHRM4CHRM5CHRM3
SCHEMBL9328997 1.00 CHRM2 (0.47) CHRM2CHRM1CHRM4CHRM5CHRM3
SCHEMBL9398875 0.82 MAPT (0.41) CHRM2CHRM1OPRM1SLC6A9MAPT
SCHEMBL5349503 0.82 MAPT (0.43) CHRM2CHRM1CNR2OPRM1MAPT
SCHEMBL9329061 0.77 MAPT (0.40) CHRM2CHRM1OPRM1ALDH1A1MAPT
SCHEMBL9517542 0.76 ALDH1A1 (0.36) CHRM2CHRM1CHRM4CHRM5CHRM3
SCHEMBL9517554 0.76 ALDH1A1 (0.36) CHRM2CHRM1CHRM4CHRM5CHRM3
SCHEMBL5206248 0.75 SLC22A1 (0.60) CHRM2CHRM1CHRM4CHRM5CHRM3
SCHEMBL5205111 0.75 SLC6A4 (0.64) CHRM2CHRM1CHRM4CHRM5CHRM3
Hydrochloric Acid SCHEMBL4859953 0.74 SLC6A4 (0.62) CHRM2CHRM1CHRM4CHRM5CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510028-B1 THIOFORMAMIDE DERIVATIVES RHONE POULENC RORER SA (FR) 1995-03-15 EP disclosed
US-5364853-A Treatment of disorders associated with vascular, respiratory, gastrointestinal tract, urinary bladder or uterus smooth muscle contraction RHONE-POULENC RORER LIMITED (GB) 1994-11-15 US disclosed
EP-0514420-B1 HYDRAZINE DERIVATIVES RHONE POULENC RORER SA (FR) 1994-09-07 EP disclosed
EP-0321274-B1 Derivatives of thioformamide MAY & BAKER LTD (GB) 1994-03-30 EP disclosed
US-5276046-A Muscle relaxants, urogenital disorders or hair growth promoter RHONE-POULENC RORER LIMITED (GB) 1994-01-04 US disclosed
US-5246950-A Smooth muscle disorders RHONE-POULENC SANTE (FR) 1993-09-21 US disclosed
EP-0390694-B1 THIOFORMAMIDE DERIVATIVES RHONE-POULENC SANTE (FR) 1993-09-01 EP disclosed
EP-0390693-B1 THIOFORMAMIDE DERIVATIVES RHONE-POULENC SANTE (FR) 1993-08-25 EP disclosed
EP-0514420-A1 HYDRAZINE DERIVATIVES. RHONE POULENC RORER SA (FR) 1992-11-25 EP disclosed
EP-0510028-A1 THIOFORMAMIDE DERIVATIVES. RHONE POULENC RORER SA (FR) 1992-10-28 EP disclosed
US-5151436-A Compounds for inhibiting hair loss in men RHONE-POULENC SANTE (FR) 1992-09-29 US disclosed
EP-0377532-B1 THIOFORMAMIDE DERIVATIVES MAY AND BAKER LIMITED (GB) 1992-07-29 EP disclosed
US-5104883-A Cardiovascular, respiratory, gastrointestirol, urogenital disorders; baldness; premature labor MAY & BAKER LIMITED (GB) 1992-04-14 US disclosed
US-5064843-A Treatment of disorders of muscle contraction RHONE-POULENC SANTE (FR) 1991-11-12 US disclosed
WO-1991012241-A1 HYDRAZINE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1991-08-22 WO disclosed
WO-1991010652-A1 THIOFORMAMIDE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1991-07-25 WO disclosed
EP-0404671-A1 Thioformamide derivatives RHONE-POULENC SANTE (FR) 1990-12-27 EP disclosed
EP-0390694-A1 Thioformamide derivatives RHONE-POULENC SANTE (FR) 1990-10-03 EP disclosed
EP-0377532-A1 Thioformamide derivatives MAY AND BAKER LIMITED (GB) 1990-07-11 EP disclosed
EP-0321274-A1 Derivatives of thioformamide RHONE POULENC RORER LIMITED (GB) 1989-06-21 EP disclosed